Journal of pain & palliative care pharmacotherapy
-
A commentary on the problem of tolerance to opioids is presented from the perspective of a person with chronic nonmalignant pain. The writer challenges the position of many clinicians and professional societies that tolerance to opioid analgesia usually is not a barrier to effective pain management. Implications for clinicians are presented.
-
J Pain Palliat Care Pharmacother · Jan 2007
Comparative StudyManagement strategies for neuropathic pain in different European countries.
Many healthcare professionals are aware of the management protocols for nociceptive pain. However, the diagnosis and management of neuropathic pain remains, for many. a confusing and uncertain topic. This paper looks at neuropathic pain management in two countries, Poland and the Republic of Ireland, and discusses the analgesic strategies for the management of this common type of pain.
-
J Pain Palliat Care Pharmacother · Jan 2007
The International Association for Hospice and Palliative Care list of essential medicines for palliative care.
The World Health Organization (WHO) requested that the International Association for Hospice and Palliative Care (IAHPC) develop a list of essential drugs for palliative care to be included in the WHO list of essential drugs. This report describes the process by which this specialized list was developed and the outcomes of that process.
-
J Pain Palliat Care Pharmacother · Jan 2007
Managing pain in chronic pancreatitis:therapeutic value of opioid treatment.
The value of opioid pharmacotherapy in the management of chronic pancreatitis pain is described. The role of kappa receptor opioid agonists and specifically oxycodone as compared to other opioid agonists is discussed. Limitations in the published studies on this topic are delineated as are difficulties in extrapolating form animal studies to clinical care.
-
Queries from European physicians about analgesic pharmacotherapy and responses from the author are presented. The topics addressed are the safety of propoxyphene, the risk of opioid dependence in nonmalignant pain, the role of ziconotide in pain management, and titration of sustained acting opioids.